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Among mammals, every cell has a biological sex, and the sex of an individual 
pervades its body and brain. In this review we describe the processes through 
which mammals become phenotypically male or female by organizational and 
activational influences of genes and hormones throughout development. We 
emphasized that the molecular and cellular changes triggered by sex 
chromosomes and steroid hormones may generate sex differences in overt 
physiological functions and behavior, but they may alternatively promote end-
point convergences between males and females. Clinical and preclinical 
evidence suggest that sex and gender differences modulate drug consumption 
as well as of the transition towards drug-promoted pathological states such as 
dependence and addiction. Additionally, sex differences in drug 
pharmacokinetics and pharmacodynamics will also influence dependence and  
addiction as well as side effects of drugs. These effects will further interact with 
socially gendered factors to result in sex differences in the access to, 
engagement in, and efficacy of any therapeutic attempt. Finally, we maintain 
that “sex-sameness” is as important as “sex differences” when building a 
complete understanding of biology for both males and females and provide a 
framework with which to classify and guide investigation into the mechanisms 
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mediating sex differences and sex-sameness.  
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Sry: Sex-determination chromosome Y; also known as TDF (testis-determining 
factor).  
LncRNA: Long non-coding RNA  
miRNA: MicroRNA. 
FoxL2: Forkhead box L2 (also known as BPES/ BPES1) 
CYP2C11: Cytochrome P450, subfamily 2, polipeptide 11. Male specific 
steroids 5-α-reductase isozyme. 
CYP2C12: Cytochrome P450, subfamily 2, polipeptide 12. Female specific 
sulfate 15β hydroxylase isozyme  
CPP: Conditioned place preference 
THC: Tetrahydrocannabinol 
ERα 
Oprm1: Mu opioid receptor gene. 
GR/ GR: Glucocorticoid receptor gene/ protein 
CRH: Corticontropin releasing hormone. 
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1.- What is sex and what is gender?  
 
Any organism’s activity is the result of a multilayered network of systems 
composed of cells. Inside each cell the elementary nodes of this network (genes 
and gene products) maintain a continuous dialog that sustains, updates or 
redefines cellular phenotypic characteristics. The cellular phenotype dictates the 
ongoing activity of a cell within its corresponding organ and system, thus finally 
limiting the range of potential responses and interactions of an individual with its 
surrounding macro-environmental factors. However, because most of the 
cellular elements involved in this interactive process are subjected to direct or 
indirect extracellular regulation, this cellular dialog is itself part of those 
produced at higher order biological modules (organs and systems) and of that 
established between the individual with its external (physical and social) 
environment.  
 
Every cell has a biological sex, and so the sex of an individual pervades this 
complex network in its entirety. In mammals and other (but not all) vertebrates, 
sex of the gonad is imposed by specific genes, and the expression of these 
genes “may interact with genotype in a manner similar to other environmental 
factors” (Ober et al., 2008). Some sex-specific elementary nodes (genes and 
gene products) are present and bias the activity and organization of the 
organism’s network from its initial constitution. As a result, a larger number of 
nodes and their reciprocal interactions become sex-biased. This, in turn, results 
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in sex differences on the organization and activity of higher order biological 
modules (cells, organs and systems). In this way, sex becomes an unavoidable 
multilayered biological context biasing the determination of the individuals’ traits 
and their responses to environmental challenges and insults. Accordingly, we 
define sex as a dynamic but stable biological trait of organisms that 
encompasses genetic, epigenetic, cellular (for our purpose, mostly but not 
exclusively neural), neurochemical (hormonal and non-hormonal) and 
morphological variability (figure 1).  
 
Gender is concerned with the inter-individual projection and embodiment of sex, 
arising from and manifesting from a differential interaction of sexed humans1 
and their physical, social and cultural environments. These environments are 
themselves different for (or have different probability of being encountered by) 
individuals, depending on their perceived sex (whether someone thinks they are 
a male or a female), thereby reinforcing or opposing the already sex-biased 
individuals’ behavior (figure1). 
 
In this text, we will be using the term “sex” as including all of its dimensions (that 
is, gender, too) but when using “gender” we will be singling out the sex-biased 
interactions of individuals within their culture and their external environment. 
 
                                                        
1  Other social animals display sex roles and sex-biased interactions with their environment that can be 
considered as “gendered behavior”. However, these gender-related manifestations are mainly observed in 
the natural (social and physical) environments of these species, a condition rarely met in preclinical 
biological research. Therefore, in this text we will use gender in the context of human behavior.  
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2.- How does sex matter? 
In mammals, sex is initially a genotype that becomes a multilayered and highly 
plastic phenotype (see article by Becker et al in this volume). Traditionally, 
although still common, views of sexual differentiation often rely on a simplified 
version of the “organizational-activational hypothesis” proposed by Phoenix and 
colleagues (1959). Thus, sexual differentiation has been often pictured as a 
“relay race” with chromosomal sex playing an initial role in gonadal 
differentiation and gonadal steroid hormones accounting for binary sex-related 
differences thereafter (figure 2A). The traditional “gonad-centric” view of sexual 
differentiation has been shown to be an over-simplification (Arnold, 2009; 
2012), however, and is being replaced by the notion that both, steroid 
hormones and sex chromosomes are proximate agents on the multifactorial 
causation of sex differences and convergences (see figure 2B), many of which 
are expressed as a continuum.  
 
According to this new scheme, the primary (already present at the zygotic 
stage) agents of sexual differentiation reside on the sex chromosome 
complement, with males having one Y and one X chromosome and females 
carrying two X chromosomes. As shown in figure 3, this results in, at least, 5 
genomic sources of sexual bias: 1) There are genes (e.g., Sry) solely contained 
in the Y chromosome that will only be expressed in the cells of some tissues 
and organs of males; 2) Early in development one X chromosome of XX 
individuals is epigenetically silenced (Plath et al., 2002). Nevertheless, around 
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25% of X protein-codifying genes (Carrell and Willard, 2005), and an unknown 
number of LncRNA- (Reinius et al., 2010) and miRNA-genes (Morgan and Bale 
2012), escape this inactivation process and are expressed at higher levels in 
XX cells (for a review see Berlecht et al., 2011); 3) The large heterocromatin 
bulk provided by an X-inactivated chromosome may act as “a sink” 
sequestering epigenetic factors required for silencing at autosomic loci, then 
leading to the enhanced expression of their genes in XX cells (Wijchers and 
Festenstein 2011); 4) Some of the genes contained in both the X and the Y 
chromosome (and therefore considered “homologous”) actually produce 
different protein isoforms (Bellot et al., 2014); and 5) XX cells are subjected to 
parental and maternal imprint on their X chromosomes, whereas XY cells are 
only affected by maternal imprinting (for a review on this and other aspects of 
sex differences and imprinting, see Bourc’his and Proudhon, 2008; for 
examples of its relevance on brain development see Gregg et al., 2010a,b).  
 
As a consequence of these constitutive genomic biases, the activity of XX and 
XY cells is intrinsically different, even when they are isolated in culture (Arnold 
and Burgoyne, 2004). Similarly, XX and XY embryos show ample gene 
expression differences before gonadal differentiation occurs (Kobayashi et al., 
2006). Therefore, the XX-XY inequality provides a set of inherent genetic and 
epigenetic sex-differences that produce an early sex-biased departure point for 
the individuals’ development (but that can also be activated and translated into 
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cell activity changes to produce or reduce other sex differences throughout an 
organism’s life-span; Davies and Wilkinson, 2006; Arnold 2009; 2012). 
 
The next crucial step in sexual development is gonadal differentiation, in which 
the Y-linked Sry gene is considered to be a crucial player (Brenan and Capel, 
2004). Sry causes testes development that leads to testosterone and MIH 
release in XY developing individuals that act to masculinize internal and 
external genitalia. In XX embryos, the lack of Sry and the sustained expression 
of some “anti-testes genes” (i.e., FoxL2; Georges et al., 2013) are responsible 
of an also active process of gonadal differentiation towards ovaries that result in 
a differently timed secretion of estrogens and progestins. Thus, gonadal 
hormones provide a divergent internal milieu that is translated during 
development into permanent organizing effects on many of an organisms’ 
tissues and organs, including the brain. 
 
These so-called ‘organizational effects’ are the consequences of the actions of 
steroid hormones on several organs and tissues during a sensitive period, 
which result in persistent anatomical and functional differences (or 
convergences) between males and females. In the brain and other non-genital 
organs this organizational sensitive period is not restricted to prenatal 
development, but extends (although showing a substrate time-declining 
sensitivity) till the end of adolescence (Schultz et al., 2009; Juraska et al., 
2013). On the other hand, the activational effects are seen mostly post-puberty 
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and are reversible (in hours to weeks). The distinction between organizational 
and activational effects is mainly a conceptual one, which probably better 
illustrates a different state of the cellular substrate than a different mode of 
action of steroid hormones (Arnold, 2009). In fact, sensitive periods derive from 
cell plasticity and are better described as a property of some cellular ensembles 
(i.e., neural circuits; Knudsen, 2004), which in the case of the organizational/ 
activational dichotomy is (as a minimum) coincidental with a widespread 
reconfiguration of the neurons’ methylome (Lister et al., 2013). 
 
The molecular mechanisms underlying organizational/ activational effects of 
gonadal secretions involve fast pharmacological actions at externalized 
receptors (Srivastava et al., 2011) as well as more delayed actions derived 
involving gene expression changes after hormone binding on nuclear receptors 
(McCarthy, 2010) and pre- and post-transcriptional processing of miRNAs 
(Morgan and Bale 2012). A full description of these molecular mechanisms is 
beyond the scope of this article. Rather, here we would like to highlight that 
steroid hormones modify the cell number, structure and activity of different 
tissues and organs, resulting in direct and indirect consequences.  
 
Direct consequences of organizational effects include the differential shaping of 
genital organs, the development of sexual secondary characteristics and the 
incorporation of sex-related differences in the structural organization of other 
organs, such as the brain. Brain organizational effects involve the promotion of 
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neurons survival, synaptogenesis and other microanatomical changes that are 
maintained through epigenetic mechanisms (McCarthy, 2010; Lenz et al., 
2012). On the other hand, the organisms’ differential developmental processes 
also introduce a series of important, albeit indirect, consequences for the 
interactions of sexed individuals with their environment (see next section).  
 
Therefore, there are two main proximal sources of sexual differentiation, namely 
sex chromosomes- and steroid hormones-effects. These two factors should not 
be regarded as mutually exclusive or temporally consecutive. Rather, they are 
concurrent and interacting (synergistic or antagonistic) sex-biasing influences 
on the organism’s genomic activity. The quantification of how many genes 
displaying sex-biased expression in adult individuals is cumbersome as it 
significantly varies among tissues and organs (and probably within smaller 
anatomical units). Nevertheless, some studies are starting to provide initial 
numbers. Yang et al. (2006) reported that 50-70% of genes display sex-biased 
expression in mouse tissues, although this proportion is noticeably lower for the 
brain (13.6%) than for other organs (i.e., liver, 72%).  These results might be 
interpreted to mean that the brain is less sexually biased than other organs (i.e., 
liver). However, it is also possible that sex differences in gene expression within 
some brain specific nuclei are diluted or masked by those occurring at other 
nuclei, leading to a bewildering description of these differences when whole 
brain is studied. On the other hand, at least for the liver, sex-biased expression 
of most (but not all) genes seems to be largely dependent on steroid- and non-
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steroid (i.e., GH) hormone effects during adulthood (Van Nas et al., 2009). 
Whether or not this also the case for sex-biased gene expression on the brain 
remains unknown and is likely to vary by brain region. 
 
The size of these sex differences in gene expression also differs depending on 
the gene, the tissue and the organism studied. Probably the most extreme case 
of sex-biased gene expression described is the 500-fold difference for the 
transcripts of the CYP2C11 and CYP2C12 in the liver of male and female 
rodents, respectively (Waxman and O’Connor, 2006). However, either in the 
liver (86.6%) or in the brain (99.2%) most genes show a sex difference smaller 
than 1.2 fold (Yang et al., 2006). Rather than prioritizing the few genes that 
exhibit big sex differences and dismissing the rest, these two sets of sex-biased 
genes should be separately considered. Thus, the few genes showing big sex 
differences in expression are likely central nodes of sex-specific physiological 
networks (i.e., CYP2C11 and CYP2C12 encode for hydrolases involved in sex-
specific pathways of steroid metabolism). Contrastingly, slightly sex-biased 
expressed genes (specially when present in a large number) are likely to bend 
the activity of networks operating in both, females and males (Yang et al., 
2006).  
 
Finally, it should be emphasized that the molecular and cellular changes 
triggered by sex chromosomes and steroid hormones may generate sex 
differences in overt physiological functions and behavior but, as hinted through 
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all this section, they may alternatively promote end-point convergences 
between males and females (De Vries, 2004; Arnold, 2014). In other words, 
some sex differences are thought to be present in order to compensate for 
other sex differences that exist in the organism at the same or at other 
biological levels. Thus, for example, X-inactivation in the female (partially) 
compensates for the different number of X chromosomes that males and 
females have. Similarly, estradiol seems to reduce (not produce) sex 
differences in the microanatomy of hippocampal neurons (McCarthy and 
Konkle, 2005), while testosterone seems to counteract the intrinsic higher 
vulnerability of XY cells towards some forms of neurodegeneration (Du et al., 
2014). By the same token, sex differences at different tissues, organs and 
systems provide agonistic or antagonistic contributions to a phenotype of 
interest. Of special relevance in the context of this review is the fact that the 
adrenal glands, the placental tissue and the brain produce steroids. Therefore, 
blood levels of estradiol and progesterone do not necessarily reflect their 
concentrations in specific brain regions (Caruso et al., 2013) and brain regional 
differences in the contents of these hormones persist even when the gonads or 
the adrenal glands are removed (Konkle and McCarthy, 2011). This out-of-the-
gonads production of steroids has not yet been properly accounted by current 
models of sexual development, but together with of other forms of 
compensation, clearly indicate that sex-biasing effects ultimately need to be 
analyzed as a set of interactions at the organism level.  
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3.- How might sex and gender matter for drug abuse and addiction? 
 
Clinical and preclinical evidence suggest that sex and gender might be relevant 
modulators of drug consumption as well as of the transition towards drug-
promoted pathological states such as dependence and addiction. Thus, as 
summarized in figure 4, gendered individuals differ in their probability of 
encountering drugs in the environment but also in the way their sexed bodies 
absorb, distribute and metabolize these substances. The different amounts 
and/or metabolites of bioavailable drugs will then interact with sexually 
differentiated brain systems. These sex differences in drug pharmacokinetics 
and pharmacodynamics will result in a plethora of wanted and unwanted effects 
that will affect the individuals’ probability of seeking and taking drugs on future 
occasions as well as their probability of developing drug-related clinical 
conditions (such as dependence and addiction). These effects will further 
interact with socially gendered factors to result in sex differences in the access 
to, engagement in, and efficacy of any therapeutic attempt.  
 
Preclinical studies have established that female rodents tend to display 
enhanced response to and motivation for most drugs of abuse, compared with 
male rats. These differences are largely dependent on the circulating levels of 
steroid hormones (for recent reviews, see Becker and Hu, 2008; Carroll and 
Anker, 2011), but there are also organizational effects of prenatal and pubertal 
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hormones during development (Perry et al., 2013a). Thus, as supported by 
experiments involving adult gonadectomy/  exogenous hormone administration 
and estrous cycle phase correlations, estradiol enhances (and, in many cases, 
progesterone decreases) the pharmacological response to acute and repeated 
psychostimulants administration (i.e., behavioral sensitization), their reinforcing 
capabilities (i.e., CPP) as well as the motivation to self-administer them 
(Quinones-Jenab and Jenab 2012). Less information is available for non-
psychostimulant drugs, but studies involving opioids, alcohol and nicotine seem 
to follow a similar trend (Carroll and Anker, 2011; Becker et al.,2012). 
 
It has been reasonably assumed that these behavioral sex-differences largely 
depend on the modulatory effects of gonadal hormones in several brain 
neurotransmission systems (for a review, see Becker et al., 2012). However, 
the same studies have also provided convincing evidence showing that these 
activational hormone effects are produced upon an already sex-biased system. 
This conclusion is sustained by three main clusters of data indicating that: 1) 
Females’ enhanced motivation for drug-taking and enhanced 
psychopharmacological response to psychostimulants is attenuated by, but 
persists after, ovariectomy; 2) Exogenous estradiol administration enhances 
these effects in ovariecteromized and intact females but it does not have the 
same facilitating effects in males, regardless of their gonadal status; and 3) 
Testosterone administration and castration have a smaller impact, if any, in 
most of these behavioral differences 
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Traditionally the behavioral sex differences that could not be accounted for by 
adult circulating hormone levels (e.g., “activational” effects) have been 
considered dependent on their “organizational” effects on the brain during an 
early sensitive period. However, this conclusion needs to be reframed within 
current views of sexual differentiation. As described in the previous section, it 
should be noted that: 1) Sexual differentiation is not restricted to the brain; 2) 
Sexual differentiation does not only occur during prenatal development; 3) Both 
sexual chromosomes and steroid hormones concurrently (synergistically and/ or 
antagonistically) contribute to the sexual differentiation of non-gonadal tissues 
and organs; and 4) Sexual differentiation promotes direct and indirect 
consequences and both of these contribute to the sex-biased behavior of 
organisms.  
 
Thus, although the most obvious locus to place sex-biased mechanisms 
accounting for sex differences in drug related behaviors is the brain, the 
contributions of other sex-biased organs should not be ruled out without specific 
assessment. In fact sex-differences on the pharmacokinetics of several drugs of 
abuse have been reported. These pharmacokinetic differences probably arise 
from the prominent sex differences on gene expression observed in the liver 
(Yang et al., 2006). Other constitutive traits of males and females (i.e., body 
composition) might also affect the amount of bioavailable drug, especially when 
highly lipophilic drugs (i.e., THC) are considered. This caution should be 
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similarly applied to drugs used as pharmacological tools in preclinical research 
or in the clinical management of addicted patients. On the other hand, sex-
differences in other organs and systems might result in a differential intensity of 
side effects of abused drugs in males and females, also biasing their future 
consumption (for a proper coverage of all these topics, see Franconi et al., in 
this volume). 
 
Focusing in the brain, anatomical and functional sex differences have been 
found in several neural circuits currently thought to play a major role in drug 
consumption and addictive behavior. These include neural circuits involved on 
motivation/ reinforcement, stress-reactivity and top-down inhibitory self-control, 
(for recent reviews, see Becker et al., 2012; Bisagno and Cadet, 2014; Becker 
and Noori in this volume). Circulating steroid levels modulate most of the 
differences observed within these circuits (Becker et al., 2012), hence mirroring 
what occurs for sex differences in other brain circuits not directly involved in 
reproduction (McCarthy and Konkle, 2005). Although direct evidence for 
hormone-mediated organizational effects on these circuits during prenatal 
development is virtually non-existent, the long-lasting remodeling that they 
suffer during adolescence is clearly influenced by gonadal (Becker, 2009; 
McCormick et al., 2010; Paus et al., 2010) and, probably, non-gonadal (i.e. 
adrenal; Spear, 2000) steroids’ levels. These changes occur at different paces, 
starting by an increase on the activity of the ascending mesolimbic-mesocortical 
dopaminergic motivational system that only years after will be counteracted by 
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the maturation of the inhibitory top-down systems of the prefrontal cortex. The 
differential timing of these maturational changes renders the adolescents’ brain 
in an unbalanced state, which results in increased risk-taking behavior 
(Steinberg, 2008) and a special sensitivity towards addiction (Chambers et al., 
2003).  
 
Appropriate genetic models to study sex-chromosomes effects have only 
recently become available (for a review on these models, see Cox et al., 2014). 
Therefore, evidence supporting the involvement of sex-chromosome effects on 
drug reinforcement/ addiction is still scarce and in, most cases, indirect. Thus, it 
has been suggested that sex chromosome complement might have a major role 
on the expression of GABA-, serotonin- and dopamine-related genes on the 
frontal cortex (Seney et al., 2013). Similarly, sex chromosome complement 
might also be involved in the observed sex differences in the motivation to 
consume saccharine (Seu et al., 2014) as well as in the habit formation for food 
(Quinn et al., 2007) and operant responding for alcohol (Barker et al., 2010). 
There data were obtained using the “four core genotypes” model, so they do not 
provide information on which specific X-Y inequalities are at play. On the other 
hand, it is known that the Y-exclusive Sry gene (besides playing a key role 
gonadal differentiation) is expressed in the tyrosine hydroxylase-expressing 
neurons of the substantia nigra (Dewing et al., 2006) and VTA (Czech et al., 
2012), where Sry transcripts regulate catecholamine synthesis and metabolism. 
Similarly, it has been reported that Sry polymorphisms affect brain ß-endorphin 
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concentration (Botbol et al., 2011). However, the functional consequences of 
these Sry actions on the brain for drug abuse/ addiction remain to be explored. 
Therefore, further research on this topic, including clinical information on drug 
consumption/ addictive behavior of individuals with sexual aneuploidic 
conditions (i.e., Turner syndrome), is needed.  
 
Finally, as mentioned in the previous section, sex-chromosome effects and 
steroid hormones alter the organisms’ morphology and activity of other tissues 
and organs, leading to direct and indirect consequences. Among the later, it is 
obvious that from birth on and even more after puberty, individuals perceive 
themselves, and are also perceived by others, as sexed individuals. This results 
in a gender-biased experience and interaction with the environment, with males 
and females putatively having different opportunities, receiving different 
consequences for their acts and learning different coping strategies (see 
Becker, Glover Reed and McClellan in this volume).  
 
Drug abuse and related phenomena provide a clear illustration of the 
importance of differentially gendered environmental interactions and 
experiences. Thus, the observed higher likelihood (2-3 fold) of adult men to be 
diagnosed by a drug abuse/ dependence disorder seems to largely be a gender 
difference in opportunity (Van Etten et al., 2001). Indeed, traditionally women 
have had less opportunity to use marijuana, cocaine, hallucinogens and heroin 
(Van Etten et al., 1999). When the influence of drug availability is ruled out, 
This article is protected by copyright. All rights reserved.
 20 
women tend to increase their rate of drug consumption faster than men do 
(Brady and Randall, 1999; Lewis et al., 2014) and once they are addicted to a 
drug they can find more difficult to quit (Lynch et al, 2001). Preclinical studies 
also find a faster transition towards habit- and compulsive-like patterns of drug 
intake in females than in males demonstrating that biological differences may 
mediate these sex differences (for recent reviews, see Caroll and Anker, 2011; 
Quinones-Jenab and Jenab 2012; Fattore et al., 2014 and in this volume). On 
the other hand, women seek for help earlier (John, 1987; Hernández-Avila et 
al., 2004) and for different reasons (Weisner and Schmidt, 1992) than men do, 
showing also a differential adherence (Mertens and Weisner, 2004) and 
response (Fox et al., 2014) to therapeutic interventions. 
 
Gendered experiences have long been considered within the realm of social 
sciences and not necessarily relevant (or at least not easily modeled) in 
biological research. This situation is changing with the fast growing increase of 
knowledge regarding epigenetic modifications of the genome, some of which 
are dependent upon sex-biased interactions with specific environmental factors. 
In rodents, for example, the sex of an individual is a major determinant of the 
quantity and quality of maternal care received (Moore and Morelli, 1979), which 
in turn results in a different epigenetic status of a large number of genes that 
might contribute to the establishment, maintenance or activation of sexual 
differences in the brain (i.e., ERα; Edelmann and Auger, 2011) but that also 
may, directly or indirectly, affect some organisms’ traits, diseases and 
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behavioral dispositions. The reduced maternal licking of female pups might 
result in reduced methylation of the Oprm1 gene at the nucleus accumbens and 
at the caudate-putamen (Hao et al., 2011). Similarly, reduced maternal care 
decreases hippocampus GR and CRH, while altering amygdala GABAA 
receptor subunit expression, then leading to an increased responsiveness of 
the stress axis (for a review, see Champagne and Curley, 2009). Although at 
present there is not evidence enough to link these gendered experiences with 
some of the observed sex-related differences in drug consumption/ addiction 
(i.e., higher impact of stress and negative emotional states on females drug 
relapse Becker et al., 2012; Bisagno and Cadet, 2014), they might serve as 
examples of how sex-biased environmental interactions alter the architecture 
and activity of the brain, hence promoting or reducing behavioral differences 
between males and females. 
 
 
4.- Sex differences and sex sameness: a framework for moving forward 
On the previous pages, we have consistently referred to sex differences. 
However, introducing sex as a relevant factor on biological research goes 
beyond collection of examples of isolated differences between females and 
males. The real challenge is to discern how and when the observed sex 
differences are established and what they mean for the biology and behavior of 
an individual. For these goals to be achieved a comprehensive “sex 
perspective” needs to be adopted. From the outset of this special issue we 
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would like to highlight two basic ideas, which are neither new nor original but 
that are worth repeating: First, not all sex differences are alike. Second, sex 
“sameness” is as important as sex differences. 
 
We agree with McCarthy et al., (2012) that there is a need to classify 
biobehavioral sex/ gender-related differences, and we think that this should be 
done according to three successive criteria as described in figure 5. 
 First, is the sex/ gender-related difference constitutive or contingent? 
Constitutive differences are those ordinarily found when comparing males and 
females, that occur under an ample variety of testing conditions and for which 
there is no identifiable trigger other than the biological sex of the subject. 
Contingent differences are those that only emerge under specific physiological 
states (i.e., injury, pregnancy, stress...) or in response to specific and 
identifiable stimuli or environmental situations (i.e., novelty).  
 
Of note, standard testing conditions in preclinical studies have traditionally been 
set and optimized for male subjects. Testing females under these male-
optimized conditions might promote contingent sex differences. Further, the 
domain at which these differences appear might be misinterpreted. For 
example, Beiko et al. (2004) found that some of the sex differences observed in 
spatial navigation on the Morris’ water maze task arise from a differential stress 
response of males and females to standard testing conditions rather than 
different learning/ memory capabilities or strategies. 
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Second, once a constitutive or contingent sex difference has been identified, it 
needs to be classified according to the statistical characteristics of the 
difference. In this regard, three main levels can be distinguished:  
-Dichotomous sex differences are those in which the variable of interest 
presents as a bivariate (“two-peaked”) distribution with each sex displaying 
one of two alternative or competing phenotypic expressions (this can also 
include the presence or absence) of the trait in one sex. It is worth 
mentioning that based on current evidence, dimorphisms are expected to 
be largely restricted to reproduction in a broad sense (i.e., also including 
courtship patterns, etc.). 
- Average sex differences are those expressed in a continuum for which 
males and females differ in their mean averages, variance or both. These 
are expected to be the majority of the cases when studying neural and 
behavioral sex differences. To attain a more accurate interpretation of this 
kind of difference, reporting statistical significance (p values) is not enough 
and appropriate effect size measures need to be included. In this regard, 
there is a real need to include measures of effect sizes in any domain of 
biology (Nakagawa & Cuthill, 2007), but in particular in biobehavioral 
studies with potential clinical or social consequences.  
Effect sizes can be interpreted in terms of the percentiles or ranks at which 
two distributions overlap, in terms of the likelihood of identifying the source 
of a value, or with reference to known effects or outcomes (Coe, 2002). 
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Therefore, effect size measures provide information on how big 
differences are (and not just on their reliability) in standardized units that 
can be compared across different studies and that ease their 
summarization though meta-analysis and similar approaches (another 
very important scientific tool that has only recently started to be 
incorporated in the drug addiction field; i.e., Noori, Helinksi and Spanagel, 
2014). 
-Number sex differences are those referring to a differential frequency or 
proportion of males and females exhibiting an otherwise identical feature 
(i.e., when a disease or phenotype is more prevalent in one sex). Number 
sex differences can superficially resemble average differences, however, 
number sex differences refers to differences on the absolute or relative 
frequency of individuals of each sex that display a trait whereas average 
sex differences refer to the distance between males and females’ 
averages (i.e., means), the magnitude of dispersion estimators (i.e., 
range) or both on a continuously measured quantitative variable. 
Therefore, there is no possible overlap between number and average 
differences when a qualitative or multi-criteria outcome is considered. 
Conversely, when using a single quantitative criterion to define the 
outcome, the distinction between both depends on how it was measured 
and analyzed. Thus, for example, it has been reported that 50% of female 
rats choose cocaine over a highly palatable food pellet while only 15% of 
males make the same choice (Perry et al., 2013b). Expressed in this way, 
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this a number difference affecting the frequency of a pre-defined outcome, 
but this difference might had been expressed as the groups’ average 
preference for cocaine over food, as well. 
Finally, the classification of sex differences should also consider their final 
significance at the functional level, then distinguishing between convergences 
and divergences. Divergences are those variations that make males and 
females distinguishable on one or more end-point features, whereas 
convergences are differences that compensate for other differences, making 
females and males more similar than they would be otherwise (see end of 
section 2). Examples of convergences are expected to grow as our knowledge 
of sex differences become more and more integrated, as it is clear that sexes 
need to remain compatible despite their different evolutionary pressures and 
ontogenetic point of departure (Ellengreen and Parsch, 2007). However, the 
existence of compensations might pose additional challenges for preclinical 
research. Thus, females and males often reach identical level of performance 
but they may do so using different behavioral strategies arising from different 
neural underpinnings. Therefore, measures more than just the quantification of 
performance can be needed to properly identify and describe behavioral sex 
differences.  
 
The classification of sex-differences in this way is helpful for thinking about how 
to integrate the variable of biological sex into a coherent theoretical framework. 
It is important to also realize that males and females are both different and 
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alike, and that both types of observations are scientifically relevant. As 
McCarthy and Konkle (2005, p.98) put it ten years ago “Understanding how the 
sexes are the same is just as important as how they differ, but the latter 
receives far less attention and little value as a genuine scientific finding”. In fact, 
we even lack an agreed terminology to refer to the commonalities found 
between males and females. Thus, at the time of writing this piece the 
expression “sex sameness” retrieved 5 pubmed publications while “sex 
differences” retrieved 181223 reports (a number that will have increased by the 
time the reader set eyes on this article). 
 
We maintain that “sex-sameness” is as important as “sex differences” when 
building a complete understanding of biology for both males and females. This 
also affects our social responsibilities as scientists. In this regard, reporting sex 
similarities is equally important as reporting sex differences. By not doing so, a 
distorted landscape of how sex affects brain function and behavior might be 
repeatedly portrayed, thereby fueling the misleading (sometimes, even 
mischievous) notion that males and females are more different than they really 
are. Indeed, the sole focus on sex-related differences has indirectly contributed 
to create a sketchy and distorted presentation of males and females as beings 
of “different planets” or with “two types of brains” that, echoing on old topics and 
prejudices, has gained fast and often uncritical social acceptance. Those 
scientifically sterile simplifications have also produced the equally simplistic 
prejudice that investigating sex differences is somehow inappropriate or 
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inconvenient, something that (as we try to show here) could not be farer from 
the truth. 
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FIGURE LEGENDS 
Figure 1.- Defining sex and gender from a systems biology perspective. 
Sex is a dynamic but stable biological trait of organisms that acts as a 
multilayered biological context biasing the determination of the individuals’ 
characteristics and their responses to environmental demands. This context 
initially arises from a sex-specific genotype that together with other with other 
sex-differentiating agents (mainly steroid hormones) produces a sex-biased 
activity of the individuals’ genotype.  As a consequence, a sex biased 
phenotypic organization and function of higher order biological modules (cells, 
tissues, organs and systems) and a series of sex-biased behaviors are 
produced. In humans (and other social animals) sex includes a relational level 
(gender) based on the perceived sex that manifests on a differential interaction 
of sexed humans and their out-of-the-organism physical, social and cultural 
environments. These environments might themselves be different for (or have 
different probability of being encountered by) individuals differing on sex, then 
providing different opportunities and divergent consequences for sex-biased 
behaviors of gendered individuals. 
Figure 2.- Two models of sexual differentiation.  
 According to traditional views of sexual differentiation (panel A) XX and XY 
individuals would be basically indistinct till the gonadal expression of the Y-
linked Sry gene Sry expression would lead the development of previously 
undifferentiated gonads as testes or, in females, the lack of Sry would lead to 
ovary development of ovaries. In the first case, testes’ secretions (mainly 
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testosterone and Müller inhibiting hormone, MIH) or their metabolites acting at a 
critical prenatal period would differentially organize in males several organs and 
tissues, such as the brain, then changing their “by default” organization (that 
observed in females); these structural sex-differences would remain largely 
silent till puberty, when a second (and more or less permanent) rise of gonadal 
steroid hormones would set them in motion, producing further sex-differences in 
physiology and behavior. On the other hand, if gonads develop as ovaries, no 
immediate secretions are produced and, in absence of “masculinizing” 
signaling, leading to the passive development of organs and tissues including 
the brain. Those feminine-differentiated tissues are activated by the raise of 
estradiol and progesterone from the ovaries.  
In contrast, current views of sexual differentiation (panel B) pose unequal 
chromosome complement as primary sources of physiological disparity between 
males and females, some of which occur before gonadal differentiation. Sry is 
still considered a major agent of gonadal differentiation, but it is known that the 
expression (i.e. Sox9) and repression (i.e.FoxL2) of other genes is needed for 
testes development. Similarly, the lack of Sry and the sustained expression of 
FoxL2 and other genes as well as other currently less known mechanisms drive 
the also active ovaries’ differentiation. Gonadal differentiation into ovaries or 
testicles leads to different hormonal milieus in females and males, resulting in 
hormonal organizing and activating (more common) actions at several tissues, 
including the brain. Within those tissues, chromosomal complement and 
gonadal steroids act as synergistic or antagonistic proximal factors leading to 
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gene expression changes and other cellular modifications that finally to produce 
or reduce phenotypic differences between females and males. Some of these 
differences are due to the presence of two X chromosomes in females and 
subsequent X-inactivation (or escape from inactivation), other differences are 
due the presence of genes on the Y chromosome not present on the X 
chromosome and still other differences are due to other chromosomic 
complement inequalities (figure 3) . 
It should be noted that, current views of sexual differentiation have left behind 
the idea of a “default” or “passive” development of females. On the other hand, 
as compared to its “traditional” conceptualization, organizational and 
activational actions of steroids are not longer so rigidly separated and they are 
currently conceived in a wider sense (see main text). A third major difference 
between both models (but not properly illustrated in these schemes) is that 
newer views do not categorize all (not even most) sexually-biased outcomes as 
binary but rather as being expressed as a continuous.  
(These figures are adapted from Arnold AP (2012) The end of gonad-centric 
sex determination in mammals. Trends Genet 28: 55-61). 
Figure 3- Sex complement introduces several sources of genomic bias  
From the zygote stage females and males differ in their sex chromosome 
complement that might manifest on sex-differences from very early stages of 
development and throughout the complete individuals’ life-span. In the male (A) 
sex chromosome complement is composed of an X   and Y chromosome. In the 
female (B) there is two X chromosomes, one of which is randomly inactivated 
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early in development leading to two distinct cell populations already at the 
gastrulation stage.  
Although X and Y chromosome have in common a series of homologous genes 
located in the so-called pseudo-autosomal regions (1), X and Y chromosome 
differ on most of their content and activity. Thus, some genes present on the X 
and Y chromosome (and therefore, usually considered “homologues”) actually 
produce different protein isoforms in males and females (3-3*); that is, they are 
just pseudo-homologous. Further, there are Y-exclusive genes (4), which are 
solely expressed in males. Similarly there are X-exclusive genes (2), which at 
some moments of development might show higher expression on females. 
Although early in development one the X chromosomes of XX individuals 
usually gets randomly inactivated though epigenetic mechanisms (5) and the 
expression of most X-exclusive genes is re-equalized in males and females, 
some portions of the X chromosome escape this process and some genes (2’), 
including some pseudo-homologous X-Y genes (3’), keep been expressed at 
higher levels in females. The inactivation of an X chromosome on XX 
individuals produces other less explored consequences:  First, the inactivated X 
chromosome remains in the nucleus as a large bulk of heterochromatin (5), 
which might act as a “sink” for silencing epigenetic factors (6) required at other 
loci, then leading to the enhanced expression of autosomal genes (not 
depicted) in XX, but not XY, cells. Second, X-inactivation affects imprinted 
genes, which are already subjected to distinct regulations in males and females. 
Thus, all paternally-imprinted X genes can potentially be expressed (7) in XY 
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cells and in XX cells at which parental X chromosome was randomly inactivated 
whereas only those escaping this process (7’) can be expressed in XX cells at 
which maternal X chromosome was inactivated. Conversely, all maternally 
imprinted X-genes can potentially be expressed in XX cells at which paternal X 
chromosome was inactivated (8), but only those escaping this process can be 
expressed in XX cells at which maternal chromosome was inactivated (8’) and 
none of them are expressed in XY cells. 
(in the figure, parental/ maternal origin of chromosomes are denoted by the 
subscripts p and m, respectively. Similarly, small arrows denote that just a 
subset of genes escaping X-inactivation process might be potentially 
expressed) 
 
Figure 4.- Schematic representation of sex- and gender-biased influences 
on drug consumption and clinically-related phenomena.  
As described in the text, gendered individuals differ in their probability of 
encountering drugs in the environment, a phenomenon that can mask the 
propensity of males and females towards drug consumption. On the other hand, 
once the individuals have taken a drug their sexed bodies might introduce sex-
related biases on the absorbance, distribution and metabolism/ elimination 
these substances. These potentially distinct amounts of bioavailable drug would 
then interact with some also sex-biased neurotransmission (i.e., dopaminergic, 
GABAergic…) systems. This might result in sex-biased reinforcement (as well 
as in a different propensity/ intensity of unwanted or aversive effects) that will 
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affect the individuals’ probability of seeking and taking drugs in future 
occasions. If so, males and females can differ in their proneness to develop 
drug-related clinical conditions (such as dependence and addiction) and, in 
such a case, socially gendered factors (along with the activity of the sex-biased 
organismic activity) might differentially influence the access, engagement and 
efficacy of any therapeutic attempt intervention.  
 
 Figure 5.- Proposed scheme for classifying sex/ gender-related 
differences. After the identification of a sex difference, it should be primarily 
asked whether it is constitutive (that is, ordinarily present) or contingent (that is, 
arising from an interaction between sex/ gender with any environmental or 
physiological event; i.e. stress, novelty, etc.). 
 Regardless its origin, the difference might be expressed as dichotomic 
(meaning that the outcome presents a clearly bimodal or “two-peaked” 
distribution) or as a difference of degree; either affecting the groups’ averages 
on a trait, either affecting the frequency at which the trait is present or absent on 
males and females (number difference).  
Finally, differences need to be classified according to their functional 
significance, as it might result on a divergence between males and males, but 
also might promote a convergence between them (e.g. when a difference 
compensate for other existent differences). Thus, for example, X chromosome 
inactivation in females should be described as a constitutive dimorphic 
convergence whereas females’ enhanced thigmotaxis in a bright open-field 
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